| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KALA BIO, Inc. | Director | Common Stock | 7.92K | $48.3K | $6.09 | Jun 11, 2024 | Direct |
| ALIMERA SCIENCES INC | Chairman Emeritus | Stock Option (Right to Buy) | 6K | Aug 1, 2023 | Direct | ||
| KALA BIO, Inc. | Director | Stock Option (right to buy) | 3.15K | Jun 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
| ALIM | ALIMERA SCIENCES INC | Aug 1, 2023 | 1 | $0 | 4 | Aug 3, 2023 | Chairman Emeritus |
| KALA | Kala Pharmaceuticals, Inc. | Jun 22, 2023 | 4 | $0 | 4 | Jun 23, 2023 | Director |
| KALA | Kala Pharmaceuticals, Inc. | May 31, 2023 | 3 | $0 | 4 | Jun 2, 2023 | Director |
| ALIM | ALIMERA SCIENCES INC | Jan 4, 2023 | 1 | $0 | 4 | Jan 6, 2023 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| ALIM | ALIMERA SCIENCES INC | Nov 2, 2021 | 1 | $0 | 4 | Nov 4, 2021 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Oct 15, 2021 | 1 | $0 | 4 | Oct 19, 2021 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Oct 15, 2021 | 0 | $0 | 3 | Oct 19, 2021 | Director |